 CAMBRIDGE, Mass., Feb. 02, 2022 GLOBE NEWSWIRE -- Tango Therapeutics, Inc. NASDAQ: TNGX, a biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that members of the management team are scheduled to participate in the following upcoming virtual investor conferences in February: 